C4X Discovery

C4X Discovery brings a new dimension to drug discovery. Using its unique NMR-based technique to determine 3D molecular structures with high accuracy, C4X Discovery is focused on optimising the design and development of medicines and partnering with the pharmaceutical sector to generate better, safer products. C4X Discovery is able to determine the bioactive 3D structures of a variety of biologically important molecules, including drugs, naturally occurring ligands and enzyme co-factors, and does this independently of traditional methods such as computational modelling and X-ray crystallography. C4X Discovery is applying its unique technology to improve the efficiency of the drug discovery process, both in partnership with the pharmaceutical industry and across its own pipeline of high-value therapeutic targets.
Company Growth (employees)
Type
Public
HQ
Manchester, GB
Founded
2007
Size (employees)
19 (est)
C4X Discovery was founded in 2007 and is headquartered in Manchester, GB

C4X Discovery Office Locations

C4X Discovery has an office in Manchester
Manchester, GB (HQ)
Manchester One 53 Portland St

C4X Discovery Metrics

C4X Discovery Financial Metrics

Revenue (2015)

£312 k

Revenue growth (2014-15), %

(50%)

Gross profit

£200 k

Gross profit margin (2015), %

64%

Market capitalization (21-Mar-2017)

£29.3 m

Closing share price (21-Mar-2017)

£0.9
C4X Discovery's current market capitalization is £29.3 m.
C4X Discovery's revenue was reported to be £312 k in FY, 2015 which is a 49.6% decrease from the previous period.
FY, 2014FY, 2015

Revenue

£619 k£312 k

Revenue growth, %

(50%)

Cost of goods sold

£23 k£112 k

Gross profit

£596 k£200 k

Gross profit Margin, %

96%64%

Operating expense total

£1.8 m£4.1 m

C4X Discovery Market Value History

C4X Discovery Company Life

You may also be interested in